The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (76.05) USD. With the latest stock price at 55.46 USD, the upside of AnaptysBio Inc based on DCF is -237.1%.
Based on the latest price of 55.46 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 237.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.8% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (211.66) - (47.69) | (76.05) |
| Upside | -481.6% - -186.0% | -237.1% |